The Patent Finder

Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same

Otsuka Pharmaceutical Co., Ltd.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 63/241,839, filed Sep 8, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,564,885Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same
In force
 · High confidence
Otsuka Pharmaceutical Co., Ltd.In force
High confidence
US 11,759,426Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same
In force
 · Low confidence
Otsuka Pharmaceutical Co., Ltd.In force
Low confidence
US 11,980,690Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same
In force
 · High confidence
Otsuka Pharmaceutical Co., Ltd.In force
High confidence
US 12,156,941Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same
In force
 · Low confidence
Otsuka Pharmaceutical Co., Ltd.In force
Low confidence
US 12,370,144Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same
In force
 · Medium confidence
Otsuka Pharmaceutical Co., Ltd.In force
Medium confidence
Application 19/249,883Centanafadine Pharmaceutical Formulations, and Methods of Making and Using Same
Pending
Not granted
Otsuka Pharmaceutical Co., Ltd.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Otsuka Pharmaceutical Co., Ltd..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited